NCT01568008View on ClinicalTrials.gov

Observational Study of Lumigan® 0.01% for Treatment of Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

CompletedOBSERVATIONAL
Enrollment

933

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Open-Angle GlaucomaOcular Hypertension
Interventions
DRUG

Bimatoprost 0.01% ophthalmic solution

Bimatoprost 0.01% ophthalmic solution eye drops at a dose and frequency as determined by the physician.

Trial Locations (1)

Unknown

Ghent

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY